Related Experiment Videos
β-secretase inhibitors for Alzheimer's disease: heading in the wrong direction?
1Department of Neurology, Harvard Medical School, and Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
The Lancet. Neurology
|June 17, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Lipid membrane remodeling by myristic acid treatment reverses Parkinson's disease α-synuclein phenotypes in patient neurons.
npj metabolic health and disease·2026
Parkinson disease is a fatty acidopathy.
Nature reviews. Neurology·2025
The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2024
RXR nuclear receptor signaling modulates lipid metabolism and triggers lysosomal clearance of alpha-synuclein in neuronal models of synucleinopathy.
Cellular and molecular life sciences : CMLS·2024
Health phenome of Parkinson's patients reveals prominent mood-sleep cluster.
Research square·2024
Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy.
The Lancet. Neurology·2026
Fluid biomarkers in the evolving care landscape of Alzheimer's disease and related disorders.
The Lancet. Neurology·2026
Scalable synthesis of both diastereomers of rac-8-aminoindolizidines and their pyrazolyl-piperidinone hybrids with promising anticancer activity.
Organic & biomolecular chemistry·2026
Multifunctional Therapeutic Potential of Corynoline: A Benzophenanthridine derived Alkaloid.
Mini reviews in medicinal chemistry·2026
Benzoxanthone Derivatives as Emerging Therapeutic Agents: A Comprehensive Review.
Mini reviews in medicinal chemistry·2026
Molecular Design and Anticancer Activities of Small-Molecule BRAF Inhibitors: A Medicinal Chemistry Perspective.
Drug development research·2026
The 1,3,4-Thiadiazole Scaffold in Medicinal Chemistry: Structural Insights, Mechanistic Pathways, and Therapeutic Outlook.
Mini reviews in medicinal chemistry·2026
Prevalence of Error Types of Synthesized Contingency Assessments.
Behavior analysis (Washington, D.C.)·2026